Paradigm Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Sell |
350
-100
| -22% | -$44.5K | 0.04% | 285 |
|
|
2025
Q1 | $218K | Hold |
450
| – | – | 0.06% | 252 |
|
|
2024
Q4 | $181K | Buy |
450
+200
| +80% | +$80.5K | 0.05% | 273 |
|
|
2024
Q3 | $116K | Hold |
250
| – | – | 0.03% | 313 |
|
|
2024
Q2 | $117K | Sell |
250
-200
| -44% | -$93.7K | 0.03% | 307 |
|
|
2024
Q1 | $188K | Sell |
450
-150
| -25% | -$62.7K | 0.05% | 298 |
|
|
2023
Q4 | $244K | Hold |
600
| – | – | 0.06% | 283 |
|
|
2023
Q3 | $209K | Hold |
600
| – | – | 0.06% | 290 |
|
|
2023
Q2 | $211K | Buy |
+600
| New | +$211K | 0.06% | 288 |
|
|
2017
Q2 | – | Sell |
-200
| Closed | -$21.9K | – | 657 |
|
|
2017
Q1 | $21.9K | Sell |
200
-450
| -69% | -$49.2K | ﹤0.01% | 608 |
|
|
2016
Q4 | $47.9K | Sell |
650
-1,200
| -65% | -$88.4K | 0.01% | 496 |
|
|
2016
Q3 | $161K | Buy |
1,850
+400
| +28% | +$34.9K | 0.03% | 341 |
|
|
2016
Q2 | $125K | Buy |
1,450
+249
| +21% | +$21.4K | 0.02% | 386 |
|
|
2016
Q1 | $95.5K | Buy |
1,201
+51
| +4% | +$4.05K | 0.02% | 471 |
|
|
2015
Q4 | $145K | Sell |
1,150
-200
| -15% | -$25.2K | 0.02% | 402 |
|
|
2015
Q3 | $141K | Sell |
1,350
-3,650
| -73% | -$380K | 0.02% | 483 |
|
|
2015
Q2 | $617K | Hold |
5,000
| – | – | 0.07% | 275 |
|
|
2015
Q1 | $590K | Buy |
+5,000
| New | +$590K | 0.07% | 284 |
|